Literature DB >> 18820307

A comparison of physicians' end-of-life decision making for non-western migrants and Dutch natives in the Netherlands.

Hilde M Buiting1, Judith A C Rietjens, Bregje D Onwuteaka-Philipsen, Paul J van der Maas, Johannes J M van Delden, Agnes van der Heide.   

Abstract

BACKGROUND: Non-western migrants have a different cultural background that influences their attitudes towards healthcare. As the first wave of this relatively young group is growing older, we investigated, for the first time, whether end-of-life decision-making practices for non-western migrants differ from Dutch natives.
METHODS: In 2005, we sent questionnaires to physicians who attended deaths identified from the central death registry of Statistics Netherlands (n = 9651; non-western migrants: n = 627, total response: 78%). We performed multivariate logistic regression analyses adjusted for age, sex and cause of death.
RESULTS: Of all deaths of non-western origin, 54% were non-sudden, whereas 67% of all deaths with a Dutch origin were non-sudden (P = 0.00). A relatively large number of non-suddenly deceased persons of non-western origin had died under the age of 65 (53%) as compared to Dutch natives (15%). Euthanasia was performed in 2.4% of all non-suddenly deceased persons in the non-western migrant group as compared to 2.7% in the native Dutch group (adjusted odds ratio = 0.82, P = 0.63). Alleviation of symptoms with a potential life-shortening effect was somewhat lower for non-western migrants (30% vs. 38%; adjusted odds ratio = 0.78, P = 0.07). Physicians decided to forgo potentially life-prolonging treatment in comparable rates (26% vs. 23%; adjusted odds ratio = 1.1, P = 0.73). Yet, the type of treatments forgone and underlying reasons differed.
CONCLUSION: Euthanasia was not less common among non-suddenly deceased non-western migrants as compared to Dutch natives. However, intensive symptom alleviation was used less frequently and forgoing potentially life-prolonging treatment involved different characteristics. These findings suggest that cultural factors may affect end-of-life decision making.

Entities:  

Mesh:

Year:  2008        PMID: 18820307     DOI: 10.1093/eurpub/ckn084

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  7 in total

1.  Selection bias in family reports on end of life with dementia in nursing homes.

Authors:  Jenny T van der Steen; Luc Deliens; Miel W Ribbe; Bregje D Onwuteaka-Philipsen
Journal:  J Palliat Med       Date:  2012-11-15       Impact factor: 2.947

2.  End of life care in high-grade glioma patients in three European countries: a comparative study.

Authors:  J A F Koekkoek; L Dirven; J C Reijneveld; E M Sizoo; H R W Pasman; T J Postma; L Deliens; R Grant; S McNamara; W Grisold; E Medicus; G Stockhammer; S Oberndorfer; B Flechl; C Marosi; M J B Taphoorn; J J Heimans
Journal:  J Neurooncol       Date:  2014-07-20       Impact factor: 4.130

3.  Perspectives on care and communication involving incurably ill Turkish and Moroccan patients, relatives and professionals: a systematic literature review.

Authors:  Fuusje M de Graaff; Patriek Mistiaen; Walter Ljm Devillé; Anneke L Francke
Journal:  BMC Palliat Care       Date:  2012-09-18       Impact factor: 3.234

4.  Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study.

Authors:  Hilde M Buiting; Mette L Rurup; Henri Wijsbek; Lia van Zuylen; Govert den Hartogh
Journal:  BMJ       Date:  2011-04-04

Review 5.  Culture and end of life care: a scoping exercise in seven European countries.

Authors:  Marjolein Gysels; Natalie Evans; Arantza Meñaca; Erin Andrew; Franco Toscani; Sylvia Finetti; H Roeline Pasman; Irene Higginson; Richard Harding; Robert Pool
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

6.  "If I had stayed back home, I would not be alive any more…" - Exploring end-of-life preferences in patients with migration background.

Authors:  Piret Paal; Johannes Bükki
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

7.  Advance care planning in glioblastoma patients: development of a disease-specific ACP program.

Authors:  Lara Fritz; Hanneke Zwinkels; Johan A F Koekkoek; Jaap C Reijneveld; Maaike J Vos; Linda Dirven; H Roeline W Pasman; Martin J B Taphoorn
Journal:  Support Care Cancer       Date:  2019-06-26       Impact factor: 3.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.